Malaria parasites cause much morbidity and mortality to their human hosts. From our evolutionary perspective, this is because virulence is positively associated with parasite transmission rate. Natural selection therefore drives virulence upwards, but only to the point where the cost to transmission caused by host death begins to outweigh the transmission benefits. In this review, we summarize data from the laboratory rodent malaria model, Plasmodium chabaudi, and field data on the human malaria parasite, P. falciparum, in relation to this virulence trade-off hypothesis. The data from both species show strong positive correlations between asexual multiplication, transmission rate, infection length, morbidity and mortality, and therefore support the underlying assumptions of the hypothesis. Moreover, the P. falciparum data show that expected total lifetime transmission of the parasite is maximized in young children in whom the fitness cost of host mortality balances the fitness benefits of higher transmission rates and slower clearance rates, thus exhibiting the hypothesized virulence trade-off. This evolutionary explanation of virulence appears to accord well with the clinical and molecular explanations of pathogenesis that involve cytoadherence, red cell invasion and immune evasion, although direct evidence of the fitness advantages of these mechanisms is scarce. One implication of this evolutionary view of virulence is that parasite populations are expected to evolve new levels of virulence in response to medical interventions such as vaccines and drugs.
INTRODUCTION
Why do parasites kill their hosts? Malaria, one such parasite that does, ranks high on the list of world health problems by causing massive human and economic loss (Sachs & Malaney 2002) . Just why malaria parasites cause so much mortality and morbidity is a question that can be addressed from different viewpoints. One view is that of the clinician, who wants to understand the pathogenesis and pathology of the disease, and thus takes a proximate view of the causes and mechanisms of virulence. Another is that of the evolutionary biologist, who wants to know what selective forces shape the parasite's virulence evolution. Recent advances in both fields are leading us towards a deeper understanding of what makes this parasite so harmful to its host. In this review, we focus on the evolutionary view now emerging from experimental studies, and link these findings to current knowledge on the molecular mechanisms of virulence.
Several features of human malaria are relevant to this discussion. First, the amount of variation in disease severity observed in the field is remarkably high. Infections range from being asymptomatic to life-threatening with case fatality rates in untreated non-immune individuals being ca. 1% and sometimes exceeding 20% (Alles et al. 1998) . Much of this variation can be attributed to prior exposure and acquired immunity, but clearly other factors operate too. These include parasite species (most mortality is due to infection with Plasmodium falciparum), age, nutrition, inoculum size, socioeconomic factors, host genetics and parasite genetics (reviewed in Greenwood et al. 1991; Marsh 1992; Baird 1998; Phillips 2001; Miller et al. 2002) . The relative importance of these different factors has not been well quantified. In one study in an area of low endemicity in Sri Lanka where P. vivax-a less virulent human malaria species than P. falciparum-predominates, of the 30% of variation in disease severity explained by known factors, approximately one-third was explained by prior exposure, one-third by host genetics and another third by other non-genetic factors pertaining to the host (Mackinnon et al. 2000) . The fact that 70% remained unexplained highlights the complex nature of the epidemiology and physiology of the disease. It also leaves room for a strong contribution from parasite genetics. Similar studies in areas where the more virulent P. falciparum predominates have not been performed.
A second feature of human malaria is that immunity is virtually never sufficient to prevent infection. In endemic areas, hosts are typically reinfected throughout their lives, although rarely become ill after experiencing 5-10 symptomatic infections (reviewed in Baird 1998) . This ineffective protection against reinfection appears to be partly attributable to parasite variation in immunogenic antigens, the strain-specific nature of the immune response to the parasite, and the relatively short-lived immune memory (reviewed in Day & Marsh 1991; Marsh 1992; Hviid 1998; Richie & Saul 2002) .
Third, transmission intensity in the field is highly variable both temporally and geographically (Molineaux & Gramiccia 1980; Hay et al. 2000) . These three features of malaria, in addition to the necessary limitations on performing experimental studies of disease in humans or primate models, have obscured our understanding of why malaria parasites cause disease, and why the outcome is so variable. Nevertheless, it is clear from several lines of evidence that there is considerable parasite genetic variation in virulence and transmissibility in the field, and that this can help explain some of the patterns of disease epidemiology (Gupta et al. 1994; Gupta & Day 1996) . In this review, we pursue the notion that parasite-based virulence-transmissibility relationships drive epidemiological and evolutionary patterns. We show how knowledge of these relationships can help predict how the parasite is likely to evolve when subjected to selection pressure by control programmes.
THE VIRULENCE EVOLUTION HYPOTHESIS
In the past two decades, there has been a realization that evolutionary biology should be able to help explain patterns of human disease (Ewald 1994; Nesse & Williams 1994; Stearns 1999) . Virulence-defined as the damage done to the host-has received most attention in this regard. Although virulence is an outcome of parasite, host and environmental factors, most evolutionary theory centres on the parasite, and we follow that tradition. The idea is that parasites do not evolve to zero virulence (i.e. to cause no reduction in host fitness) because virulence incurs benefits as well as costs to the lifetime transmission success of the parasite, i.e. its Darwinian fitness. The benefit of virulence is higher transmission rate: by extracting more resources from the host, the parasite is able to make more transmissible forms per unit time. Another benefit is slower parasite clearance rate and hence a longer infection from which to transmit. However, the cost of virulence is premature host death which shortens the lifetime of the infection. Thus there is a trade-off between 'how fast' and 'how long' the parasite transmits. This leads to maximum lifetime transmission occurring in parasites that have intermediate virulence, and this is therefore the outcome of natural selection (see Frank (1996) for a review of the theory, and figure 1 for a diagrammatic explanation).
This trade-off view of virulence evolution has generated a large body of theory, and elaborations of it continue to multiply. These theoretical studies are often pinned on claims that 'virulence management' will be helpful in combating diseases of medical and veterinary importance (Dieckmann et al. 2001) . Unfortunately, the pace of theory is not matched by data to support it. Even the most basic assumption of a positive virulence-transmissibility relationship implicit in the trade-off argument (figure 1) remains largely untested, and is currently justified by only a few observations. Direct evidence that there is a positive relationship between transmission rate and virulence among natural pathogen isolates has been found for myxomatosis virus in rabbits (Fenner et al. 1956 ), typhoid bacteria in mice (Greenwood et al. 1936) , trypanosomes in mice (Turner et al. 1995) , microsporidia in Daphnia (Ebert 1994) and malaria in mice (Mackinnon & Read 1999a; Ferguson et al. 2003b) . Indirect evidence has also been found from experimental evolution studies (Bull et al. 1991; Ebert & Mangin 1997; Turner et al. 1998; Mackinnon & Read 1999b; Messenger et al. 1999; Elena 2001) or cross-species comparisons (Herre 1993; Clayton & Tompkins 1994; Ewald 1994) . Evidence that host Phil. Trans. R. Soc. Lond. B (2004) death reduces lifetime transmission is rare (Fenner et al. 1956 ) and there are pathogens that are claimed to not fit the trade-off model (Lipsitch & Moxon 1997; Weiss 2002; Ebert & Bull 2003) , although direct data are lacking in these cases. Further, there are alternative hypotheses that challenge the adaptive hypothesis. For example, virulence may be an accidental and rare by-product of normally asymptomatic infection (Levin & Svanborg-Eden 1990) , or the outcome of short-term within-host evolution for rapid proliferation, but with detrimental effects on between-host transmission and hence evolutionary stability (Levin & Bull 1994) .
The lack of data on genetic variation and covariation among the key life-history traits of parasites-virulence, transmission rate and clearance rate-is surprising given that these traits determine the population-level burden of disease. In fact, the aim of control programmes (e.g. drugs and vaccines) is to reduce the burden by acting directly on these traits. The success of such programmes will depend on what parasite and host factors influence these traits and how they are biologically related to each other. Importantly, if these traits really are the prime determinants of parasite fitness, then control programmes will do more than just reduce disease: they will bring about evolutionary change in the parasite population with long-term consequences. With these considerations in mind, and given our firm belief that evolutionary models need to be grounded and tested in specific disease contexts, we set out to examine the virulence adaptive trade-off hypothesis using the P. chabaudi rodent malaria as a model. Our immediate aims were twofold: first, to test the assumptions underlying the evolutionary theory in a microparasite of medical importance, and second, to help us understand the evolutionary forces driving malaria parasite virulence. Our ultimate objective is to determine the key parasite properties that cause virulence in human malaria.
PLASMODIUM CHABAUDI AS A MODEL FOR VIRULENCE EVOLUTION
All Plasmodium species have an asexual haploid life stage that replicates rapidly in the red blood cells of their vertebrate host, thereby causing anaemia and other general pathology. These asexual stages occasionally produce sexual stages (gametocytes) which themselves do not replicate, but when ingested by Anopheles mosquitoes, fuse to from a diploid zygote, undergo meiosis, then proliferate to yield forms that are transmitted back to vertebrate hosts. Gametocytes are produced throughout the infection, and are generally rare, typically constituting ca. 1% of the total parasite population. Asexual parasite densities reach a maximum of 10 8 to 10 9 ml Ϫ1 after about one week of becoming detectable in the blood, and then decline in a log-linear fashion over the next two to six months. The similarity in infection pattern across Plasmodium species is illustrated in figure 2 .
The rodent malaria species, P. chabaudi, is the laboratory model that has been most used for addressing evolutionary questions. This is because it shares many infection characteristics with P. falciparum, the most virulent of the human-infecting species. Both species have a relative lack of preference for young red blood cells (reticulocytes) over older ones (normocytes) (Pasvol et al. 1980; Clough et al. 1998a) compared with many other species (e.g. P. vivax, P. berghei and P. yoelii ) which show a marked preference for young red blood cells (reticulocytes) (Garnham 1966) . Plasmodium falciparum and P. chabaudi also both display cytoadherence: the sticking of parasitized cells to other host cells during the last half of the replication cycle. Cytoadherence takes several forms. One is sequestration: the withdrawal of parasites from the peripheral circulation to the microvasculature where they adhere to endothelial cells. Another is rosetting: the adherence of uninfected red blood cells to infected cells to form small clusters of cells. A third is adherence of infected cells to infected cells. All three properties have been implicated as virulence factors in human malaria Langreth & Peterson 1985; MacPherson et al. 1985; Carlson et al. 1990; Rowe et al. 1995; Roberts et al. 2000; Pain et al. 2001) . Finally, both species provoke strain-specific immunity (Taliaferro 1949; Jeffery 1966; Jarra & Brown 1985; Snounou et al. 1989; Mota et al. 1998) , and both species undergo clonal antigenic variation (McLean et al. 1982; Biggs et al. 1991; Roberts et al. 1992) . However, there are some marked differences between P. falciparum in the field and P. chabaudi in laboratory mice. The maximum parasitaemia reached in P. falciparum typically does not exceed 5% or 10 8 parasites ml Ϫ1 (e.g. Field & Niven 1937; Collins & Jeffery 1999 ) and all-case fatality rates are ca. 0.1-1% (Molineaux & Gramiccia 1980; Greenwood et al. 1987; Alles et al. 1998; Snow et al. 1999) . In P. chabaudi, peak parasitaemia typically Phil. Trans. R. Soc. Lond. B (2004) reaches 30% or 10 9 ml Ϫ1 in laboratory mice (e.g. Jarra & Brown 1985) and mortality rates are typically ca. 5-20% in C57Bl/6J mice and much higher in less resistant mouse genotypes such as CBA/Ca and DBA (Stevenson et al. 1982) . Levels of peak parasitaemia of P. chabaudi in its natural host, Thamnomys rutilans, are undocumented, though infections can be severe (Landau 1965 (Landau , 1966 , and in Grammomys surdaster, a very closely related and sympatric species to T. rutilans (Ellerman 1940) , infections are similar to those in laboratory mice and often cause death (D. Walliker and R. Carter, personal communication) . In P. falciparum, infections usually last less than six months (Diebner et al. 2000; Collins & Jeffery 2003) and almost always less than a year (Dietz et al. 1980) . Infections of P. chabaudi in their natural host in its natural environment are known to occur throughout this host's life (ca. 2 years (Landau & Chabaud 1965) ) probably because of the existence of dormant forms in the liver (Landau & Chabaud 1965; Landau & Killick-Kendrick 1966; Landau & Chabaud 1968) or other latent forms of the parasite in the lymph system . Chronic P. chabaudi infections lasting up to at least 1 year, though more typically two to three months, are also observed in mice (D. Walliker and R. Carter, personal communication). Cerebral malaria, a syndrome of P. falciparum in which parasites become lodged in the brain as a result of cytoadherence, and the form of disease responsible for most malaria-related deaths in Africa , is not an obvious feature of P. chabaudi. Lesions (Vuong et al. 1999 ) and parasites (Mota et al. 2000) have been found in the brain of P. chabaudi-infected mice, but most sequestration takes place in other vital organs such as the liver (Cox et al. 1987; Mota et al. 2000) . Brain involvement similar to cerebral malaria does occur in related rodent species (P. berghei, Rest (1982) which also sequesters in other organs (Alger 1963) , and in P. yoelii, Yoeli & Hargreaves 1974; Kaul et al. 1994) , but this appears to be only after adaptation to the novel host (mice) through serial passage. In addition to its similarities with P. falciparum, the P. chabaudi system is attractive as a model because of the availability of diverse parasite strains cryopreserved shortly after they were derived from the wild (Beale et al. 1978) , the availability of host genotypes with well-characterized genetics, the ability to measure virulence, multiplication rate, gametocyte production, transmission to mosquitoes, cytoadherence and antigenic variation in vivo, and the ability to manipulate immunity and other factors that moderate virulence.
VIRULENCE-TRANSMISSIBILITY RELATIONSHIPS IN PLASMODIUM CHABAUDI
There are four main traits relevant to the evolution of virulence that we have quantified in the P. chabaudi system. Parasite multiplication ability, or 'growth', was measured as either the rate at which the asexual parasite population increased during the early stage of the infection, or as the maximum asexual parasite density or proportion of red blood cells infected (parasitaemia). Note that although these measures focus on multiplication rate during the acute phase, we are interested in effective multiplication rates throughout the infection. Virulence was Phil. Trans. R. Soc. Lond. B (2004) measured as the maximum or total amount of red blood cells destroyed by the infection, or the maximum or total amount of liveweight lost by the mouse, or less commonly, by death of the mouse. Note that, strictly speaking, virulence in the theoretical models is defined as the rate of host death, whereas in these experiments, we mainly measured morbidity. However, because of the positive relationship between host mortality and morbidity (Timms et al. 2001; Mackinnon et al. 2002a; Ferguson et al. 2003b) , we use the term virulence to encompass both morbidity and mortality. Transmission rate was measured as the gametocyte density or proportion of cells infected with gametocytes (gametocytaemia): when averaged over time, this provided an indicator of lifetime transmission potential. Sometimes, actual transmission to mosquitoes was measured as the proportion of mosquitoes that became infected when allowed to feed on the mouse on a limited number of days around peak gametocytaemia (Mackinnon & Read 1999a; Ferguson et al. 2003b) . Gametocyte density is a good predictor of transmission to mosquitoes in P. chabaudi Mackinnon & Read 1999a; Buckling & Read 2001) . Transmission back to the host has not been quantified in this system. Clearance rate was measured as the rate at which log parasite density decreased from peak parasitaemia to sub-detectable levels. As there are secondary peaks of parasitaemia during this time, a straight line was fitted through either all points or all peaks, and its slope used to indicate clearance rate.
Using a panel of 10 cloned parasite lines recently isolated from the wild, we showed that parasite clones that have high multiplication rate produce more asexual parasites, generate more gametocytes, infect more mosquitoes and have longer infections than clones with low multiplication rates (Mackinnon & Read 1999a ,b, 2002a , 2003 Ferguson et al. 2003b) . They also cause more anaemia and weight loss (morbidity) (Mackinnon & Read 1999a ,b, 2002a , 2003 Ferguson et al. 2003b) , and cause more mortality (Timms et al. 2001; Mackinnon et al. 2002a) . Mortality reduced total lifetime gametocyte production in one experiment by 74% (Mackinnon et al. 2002a ), but not in another experiment (Ferguson et al. 2003b) . When the same parasite clones were injected into immunized as well as naive mice, it was found that immunity reduced growth rate, virulence, transmission rate and infection length, and that the positive relationships between these traits found in naive mice were also found in immunized mice . Within a small range of conditions typical of one experiment, these relationships are quite noisy though generally statistically significant. Figure 3 shows these relationships in data pooled across four separate experiments that included 13 different parasite lines, three host genotypes, naive and immunized mice, and both host sexes. Taking this broader view, the phenotypic relationships among traits are very strong, and consistent
Phil. Trans. R. Soc. Lond. B (2004) across, as well as within, experimental groups (figure 3a,b). When data were averaged over each parasite clone, these relationships were shown to have a parasite genetic basis (figure 3c,d ). Thus the assumptions of the adaptive tradeoff virulence model (figure 1) are clearly supported by the experimental data from P. chabaudi.
We also found that growth rate early in the infection and late in the infection are both correlated to maximum parasitaemia (figure 4). Thus despite the difference in factors thought to limit growth early versus late in the infection, it appears that successful multiplication is at least partly determined by a common mechanism that operates at all stages of the infection.
The positive virulence-transmissibility relationships are also borne out when parasites undergo selection and adaptation. When parasite lines of various species are serially passaged (i.e. by transfer of asexual blood stages to new hosts by syringe rather than sexual stages by the mosquito), they often become more virulent, and generate higher parasite densities (James et al. 1936; Greenberg & Kendrick 1956; Sergent & Poncet 1959; Galli & Brambilla 1967 Read 1999b). In some cases this virulence increase has been accompanied by an increase in transmission potential (James et al. 1936; Mackinnon & Read 1999b) . However, there are other examples where virulence has decreased with serial passage (Greenberg & Kendrick 1956; Carrescia & Arcolea 1957; Rest 1982) and where gametocyte production has been reduced by passage in vivo (Dearsly et al. 1990) or lost in vitro (Day et al. 1993) . In the absence of regular passage through mosquitoes and hence maintenance of selection for the ability to sexually reproduce, results from serial passage experiments must be treated with caution. What these experiments do clearly show, however, is that malaria parasites can adapt at a remarkable rate. Within 150 replication cycles, a parasite line that caused virtually no weight loss and had a peak parasitaemia of 10% changed to cause 10% of body weight loss and a peak parasitaemia of 25% (Mackinnon & Read 1999b 70% of mice whereas the ancestral line incurred zero mortality (Mackinnon et al. 2002a) . Undoubtedly, this reflects adaptation of P. chabaudi to its novel laboratory host, the mouse. Regardless of the cause, the fact that these parasites can adapt so quickly is vitally important to the question of whether noticeable virulence evolution will occur in response to vaccination programmes or other interventions in human malaria.
VIRULENCE-TRANSMISSIBILITY RELATIONSHIPS IN PLASMODIUM FALCIPARUM
Do these virulence-transmissibility relationships hold for P. falciparum? The best source of in vivo data in humans comes from the treatment of patients with neurosyphilis by infection with malaria. Between-strain variation in parasite growth rate and virulence has been demonstrated in these data from P. falciparum ( James et al. 1932; Jeffery & Eyles 1955; Gravenor et al. 1995; Simpson et al. 2002; Read et al. 2003) as have differences in infection length (Jeffery & Eyles 1954 , 1955 , infectivity to mosquitoes ( Jeffery & Eyles 1955) and gametocyte circulation time . Variation in asexual growth rate in vitro of wild-caught P. falciparum isolates exists and, importantly, this correlates positively to in vivo virulence (Chotivanich et al. 2000) . Between-strain variation in gametocyte production in vitro in P. falciparum has also been demonstrated (Graves et al. 1984) . There is also evidence of between-strain variation for some of these characteristics in P. vivax (reviewed in McKenzie et al. 2002) . However, there appear to be only two published studies, one in P. falciparum and one in P. vivax, that have examined the relationships among virulence, transmission, growth rate and infection length. The study in P. falciparum compared the El Limon strain from a high-transmission area in Central America (Panama) with the SanteeCooper strain from a low-transmission area in North America (South Carolina) and found that the El Limon strain was more virulent, more persistent and had more transmission to mosquitoes than the Santee-Cooper strain (Jeffery & Eyles 1955) , consistent with the virulence evolution hypothesis. A subsequent analysis of these data found no differences between these strains in parasite multiplication rate early in the infection (Simpson et al. 1999) . Within strains, relationships between virulence and transmissibility have not yet been reported from these data. Another study in P. vivax found that repeated passage through humans resulted in a parasite line that had higher asexual parasitaemias, fevers, mortality and transmission to mosquitoes than its ancestral form (James et al. 1936) .
In the absence of systematic studies of virulence-transmissibility relationships in human malaria parasites, we resorted to an analysis of field data from a large epidemiological survey in a malaria-endemic area in Nigeria where P. falciparum predominates (the Garki Project (Molineaux & Gramiccia 1980) ). Such data introduce many factors other than parasite genetics that might impact on the growth-rate-virulence-clearance-ratetransmissibility relationships, such as host age, immune status and force of infection. Whereas it is only the genetic relationships among parasite traits that determine the direction of virulence evolution, which cannot be extracted from these data, the analysis revealed broad . Relationships between asexual parasitaemia, virulence and transmission in human malaria in the field. Each point represents the average for an age-class, with symbols of decreasing size representing younger than 1, 1-4, 5-8, 9-18, 19-28, 29-43 and older than 43-year-olds, respectively, as labelled in (a). Data in (a), (c) and (e) are from the Garki project 1 and are derived from eight cross-sectional epidemiological surveys performed every 10 weeks during the baseline phase (Molineaux & Gramiccia 1980) . Average gametocytaemia 2 (a), mortality rate 3 (c) and clearance time for each new infection allowing for superinfection 4 (e) increase with asexual parasitaemias 2 . In (e), mean values for the three parasite species in this area across all ages are also shown by the open square symbols (P.f., Plasmodium falciparum; P.m., P. malariae; P.o., P. ovale). Data in (b) are from Tchuinkam et al. (1993) 5 and illustrate that the relationship between infectivity to mosquitoes and log gametocyte density is positive and approximately linear. Data in (d ) are from Field & Niven (1937) and, as in (c), illustrate that mortality increases with log asexual parasite density in a linear fashion (see endnotes for details). Data are reproduced with permission.
biological relationships between virulence and transmissibility consistent with the assumptions of the virulence evolution theory (figure 1). Figure 5a shows that asexual parasite density and gametocyte density among infected hosts are highly correlated across age groups and across seasons. Data from a separate study (Tchuinkam et al. 1993 ) illustrate how transmission of P. falciparum to mosquitoes increases with the log of gametocyte density, this in a linear way (figure 5b), consistent with other field studies on this relationship (reviewed in Carter & Graves and McKenzie et al. (2002) for data on P. ovale and P. vivax). Thus it is reasonable to assume that transmission to mosquitoes in the Garki Project was a log-linear function of the average gametocyte densities reported, further assuming that host age does not alter the infectivity per gametocyte, as supported by most studies where this has been examined (Rutledge & Gould 1969; Graves et al. 1988; Tchuinkam et al. 1993) . . Different sized dots above the bars correspond to different age-classes and correspond to those in the upper panel and in figure 5. These two panels thus distinguish between the effects of host quality and host quantity on parasite fitness. The analysis suggests that evolution has maximized parasite fitness for host types that contribute most to transmission, i.e. children under 9 years of age who account for 71% of the total transmission.
seasons. Figure 5e shows that clearance rates decrease with asexual densities. It also shows that two other species, P. ovale and P. malariae, fit in well with the curves for P. falciparum: thus these relationships may hold across, as well as within, Plasmodium species. Indeed, data from malaria therapy infections with P. ovale , P. malariae (McKenzie et al. 2001) and P. vivax (McKenzie et al. 2002) confirm the lower average asexual parasitaemias, lower gametocytaemias, lower virulence and faster clearance rates than for P. falciparum, thus further supporting this argument.
The data in figure 5 can be combined to calculate the expected lifetime transmission (i.e. fitness) of the parasite as a function of asexual multiplication. When this is done, the hypothesized virulence trade-off from evolutionary theory is revealed (figure 6a). Parasite fitness reached its Phil. Trans. R. Soc. Lond. B (2004) maximum in 1-year-olds or younger and was almost equal to that in the 1-4-year-olds, despite the latter group having lower transmission rates (figure 5a). This is because of the higher mortality rates in under-1-year-olds or younger (figure 5c), which is balanced by their higher transmission rates. In adults, fitness was much less than that in children (by about 10-fold): this was because of lower gametocyte densities and shorter infections, thereby clearly illustrating the fitness benefits associated with virulence. Thus the benefits and costs of virulence assumed by theory are supported by these data. Note that these data, unlike those from P. chabaudi, do not directly support the trade-off proposed by the evolutionary models, which require that virulence variation is generated by parasite genetics rather than host factors: they are nonetheless consistent with the theory. They also provide an excellent example of how parasite fitness is maximized at intermediate levels of virulence: this is for the same reasons assumed by the evolutionary hypothesis described above.
This example from the field is also useful for demonstrating the main sources of selection on the parasite population. Calculating the relative contribution to total transmission in the population reveals that children under 9 years of age, in addition to having near-maximal per-host fitness, are also the class that contribute most to the fitness of the total population (figure 6b). Thus natural selection appears to have optimized fitness to suit the most abundant host type. This is just as expected from evolutionary theory, and has also been observed in other natural systems (e.g. Herre 1987; West & Herre 1998) . Our overall conclusion from this analysis is that, in the field, too-virulent malaria parasites are maintained in the population by selection pressure for high transmission from semi-immune hosts, and that this is at the expense of young children who lack immune protection. Assuming that parasite strain differences in virulence are fixed (i.e. parasites do not modify their virulence according to which sort of host they are in), the virulence trade-off hypothesis can thus explain why malaria parasites kill some of their human hosts.
IMPLICATIONS FOR VACCINES AND OTHER CONTROL MEASURES
Immunity to malaria in humans is almost never perfect (i.e. infection-blocking), but does protect against disease. We reasoned that if, as the data suggest, asexual multiplication was really the key to transmission and virulence, then immunity that reduced asexual multiplication would also reduce both these fitness traits according to the general biological relationship between them. To test this hypothesis, we tested 10 clones of P. chabaudi for their growth-virulence-transmissibility relationships in naive and immunized mice. As expected, immunity reduced all three traits and hence overall parasite fitness, and the positive genetic relationships between multiplication rate, morbidity, infection length and transmission previously demonstrated in naive mice were also maintained in immunized mice. Parasite clones also maintained their virulence ranking across naive and immune hosts: thus clones were consistent in their relative fitness across immune environments .
Given these findings, we built a model to predict the impact of anti-growth rate (blood-stage) vaccines on the evolution of virulence in microparasites in general, which we applied to the problem of endemic malaria area (Gandon et al. 2001) . We predicted that intrinsic virulence would increase as the degree of vaccine coverage and efficacy increased. This is because immunity protects the parasite from the fitness cost of virulence (host death) while still putting pressure on higher transmission. The consequences of this virulence evolution would be realized at two levels. Individual hosts would now be exposed to more dangerous parasites so that those hosts unfortunate enough to be unvaccinated (there would always be some) would suffer higher mortality. At the population level, there might be lower total mortality if vaccination coverage was high, but this benefit would be less than if parasite evolution had not occurred. Thus evolution would erode the benefits of vaccination. Retreating from a failing vaccination programme would lead to more unvaccinated people being at risk from these vaccine-generated virulent strains, and thus would be highly undesirable.
In the same theoretical framework, we also examined the impact of other types of vaccine currently under development for malaria: anti-toxin vaccines, anti-infection vaccines and transmission-blocking vaccines (reviewed in Hoffman 1996) . We found that anti-toxin vaccines, like anti-growth-rate vaccines, would select for higher virulence because they also release the parasite from the fitness constraint of host death. However, anti-infection and transmission-blocking vaccines would have no such effects. This is because their transmission-blocking effects are decoupled from their virulence, and therefore they do not alter the costs and benefits of virulence (Gandon et al. 2001) . These predictions for vaccines can be applied more generally to other control measures such as drugs and bednets. For example, bednets may act like infectionblocking or transmission-blocking vaccines, whereas drugs may act like anti-growth rate vaccines. Therefore, if this theory is relevant to field malaria, there are clear choices to be made among control strategies that will yield benefits in the long term as well as the short term. Fortunately, the most desirable approaches to control from an evolutionary and epidemiological point of view-bednets and other transmission-reducing measures-are also the cheapest, the easiest to implement and the most socially acceptable of the current options.
What is the long term in this context? The rate of adaptation of malaria parasite populations can be remarkably high in the laboratory (Greenberg & Kendrick 1956; Dearsly et al. 1990; Mackinnon & Read 1999b ) but we do not know the rates of change in the field. The fact that drug resistance becomes a problem within 5-30 years of first using a drug is indicative of their potential to evolve rapidly (Peters 1987) . Changes in population frequencies of antigenic types after a field vaccine trial (Genton et al. 2002) have already been documented, and escape mutants under vaccine pressure in experimental systems have also been observed (David et al. 1985 ). Our theoretical model, which was based on well-known parameter values derived from field data (Dietz et al. 1980; Aron & May 1982; Nedelman 1984; Struchiner et al. 1989) , predicts that a new virulent mutant will reach a frequency of 50% in less than 40 years (Gandon et al. 2001 adaptation was purely phenotypic and these changes were carried over to new hosts, i.e. stable, increases in virulence may be more easily reversible than if the change was genetic. However, reversal would necessarily come at the cost of host mortality unless an alternative form of selection pressure could be found.
MOLECULAR MECHANISMS FOR VIRULENCE IN RELATION TO PARASITE FITNESS
This evolutionary perspective differs from, although is not at odds with, the clinical and molecular explanations of malaria virulence which focus on 'how' rather than 'why' parasites cause damage to their hosts. Clinicians explain severe disease in terms of three main factors: anaemia, parasite toxins and cytoadherence (White & Ho 1992; Newbold et al. 1997 ). All of these share the same root cause: unrestrained asexual parasite multiplication (Field & Niven 1937; Kitchen 1949; Molineaux et al. 2001 ). What we are proposing here is that high multiplication ability is the key to parasite fitness and that virulence is an unfortunate side-effect of this. To illustrate how these two perspectives can be merged, we have modified the diagram of explaining the clinical basis of severe malarial disease to incorporate the transmission consequences of high multiplication rate and virulence (figure 7).
If asexual multiplication really is the Achilles' heel of parasite fitness, what are the mechanisms by which this is achieved? Three parasite properties stand out as candidates for virulence and fitness promoters: cytoadherence, antigenic variation and red cell invasibility. Whereas the molecular bases of these phenotypes have been reviewed recently (Ho & White 1999; Kyes et al. 2001) , our purpose here is to relate this knowledge to the question of parasite fitness.
(a) Cytoadherence Cytoadherence refers to a group of related phenomena in which parasite-infected cells adhere to other host cells during the last half of the parasite's replication cycle: these host cells include endothelial cells in the post-capillary venules ('sequestering'), uninfected red blood cells ('rosetting'), infected red blood cells ('autoagglutination' or 'clumping') and leucocytes. In isolation or by interacting (Handunetti et al. 1992; Ho & White 1999) , and perhaps exacerbated by reduced red cell deformability (Dondorp et al. 1997) , these cytoadherence phenotypes lead to a slowing and obstruction of blood flow in the post-capillary venules (MacPherson et al. 1985; RaventosSuarez et al. 1985; Kaul et al. 1991 Kaul et al. , 1994 Nash et al. 1992 ) and lead to hypoxia and nitric oxide-related pathology (Clark & Rockett 1996; Dondorp et al. 1998) . Together, these can lead to coma, organ failure and death. Many studies, both in vitro and in vivo, have shown associations between binding ability to at least some host cell receptors (principally CD36, ICAM-1 and CR1) and the occurrence of the most severe forms of disease (MacPherson et al. 1985; Carlson et al. 1990; Ho et al. 1991; Pongponratn et al. 1991; Treutiger et al. 1992; Ringwald et al. 1993; Rowe et al. 1995; Newbold et al. 1997 Newbold et al. , 1999 Kun et al. 1998; Roberts et al. 2000; Pain et al. 2001) , whereas a few studies have found no such relationship al-Yaman et al. 1995; Angkasekwinai et al. 1998; Rogerson et al. 1999) or a reverse one (Rogerson et al. 1999) . However, there is a lot to understand about how exactly cytoadherence leads to severe pathology (Berendt et al. 1994; Clark & Rockett 1994; Clark & Schofield 2000; Cooke et al. 2000) . Moreover, and particularly important for the discussion here, these severe forms of disease are rare, and associations between cytoadherence and disease severity among most malaria patients who experience relatively mild, non-life-threatening forms of the disease have not been found. Thus, given the fitness cost to the parasite of host death (immediate cessation of transmission), it is difficult to explain why cytoadherence is so common in nature. Rosetting has been found in all Plasmodium species studied (Wahlgren 1986; David et al. 1988; Handunetti et al. 1989; Udomsangpetch et al. 1991 Udomsangpetch et al. , 1995 Angus et al. 1996) and varies between parasite strains within species Reeder et al. 1994; al-Yaman et al. 1995; Rowe et al. 1995; Mackinnon et al. 2002b) . Sequestering does not occur in all species, appears to be a property of all parasite strains within species (although quantitative data are lacking on this point), and varies both between species (Alger 1963; Garnham 1966; Miller 1969; Desowitz et al. 1969; Yoeli & Hargreaves 1974; Cox et al. 1987; David et al. 1988; Gilks et al. 1990; Mota et al. 2000) and within species (reviewed in Newbold et al. 1997 Newbold et al. , 1999 in the degree and sites of sequestration. Autoagglutination has only been looked for and found in P. falciparum and P. knowlesi (Knisely et al. 1941 ) and has been shown to vary between isolates in P. falciparum Pain et al. 2001) . The ubiquity of cytoadherence in the Plasmodium genus suggests that there is a beneficial as well as costly role of cytoadherence in parasite fitness. Alternatives to this adaptive explanation of cytoadherence are that cytoadherence-related death is just a rare aberration arising from excesses of within-host, short-sighted evolution (Levin & Bull 1994) , or is some marker or by-product of another disease-related process Clough et al. 1998a ) such as tumour necrosis factor production (Allan et al. 1993; Ringwald et al. 1993) or malaria infection-induced structural changes to infected and uninfected red blood cells (Dondorp et al. 1997; Chotivanich et al. 1998) . If cytoadherence is an epiphenomenon of some other disease-causing process, we would expect our evolutionary analysis above to apply to that other process.
If cytoadherence does confer a fitness benefit, then how does it work? The most plausible argument is that it promotes asexual parasite population growth and hence production of gametocytes. Cytoadherence has been mooted to be a growth factor for two different, not mutually exclusive, reasons. Either it could increase the parasite's 'birth rate', or decrease the parasite's 'death rate', both of which have an impact on parasite population density. Hypotheses that have been proposed about how cytoadherence increases birth rates are as follows: (i) rosetting and/or sequestering increases the contact between uninfected cells and newly released merozoites, thus promoting invasion efficiency (Handunetti et al. 1989; Wahlgren et al. 1989) ; (ii) rosetting attracts the bursting schizont young cells that are more favourable for parasite growth (Clough et al. 1998a) , or that have receptors suitable for merozoite invasion; (iii) sequestering provides a more favourable environment for parasite maturation (Ho & White 1999) ; and (iv) rosetting and/or sequestering promotes synchrony which in turn maximizes the number of viable merozoites per infected cell. The first two hypotheses have been directly tested only once by using an in vitro system and were rejected (Clough et al. 1998a ). However, one study has shown an association between rosetting capacity in vitro and the asexual parasite density of the host at the time of blood donation (Rowe et al. 2002) . Further indirect evidence in support of the birthrate hypotheses comes from field data on severe disease: these are the positive link in P. falciparum between severe malaria and parasite multiplication potential measured in vitro (Chotivanich et al. 2000) , and the correlation between cytoadherence in vitro and the incidence of severe anaemia and therefore perhaps asexual multiplication rate. Laboratory studies that also support the birth-rate argument are the higher growth rate and higher sequestration in a highly virulent mutant clone of P. yoelii compared with avirulent clones (Yoeli & Hargreaves 1974; Yoeli et al. 1975) , and the lower acute phase growth rate and virulence in a line of P. falciparum that had lost the ability to sequester (Langreth & Peterson 1985) . However, in another study of a non-sequestering line in P. chabaudi, the rate of acute phase growth was similar to that of sequestering lines (Gilks et al. 1990) .
Arguments for how cytoadherence reduces parasite death rates revolve around immune-clearance mechanisms. Specific hypotheses that have been proposed include the following: (i) parasites sequester to avoid being circulated through the spleen where immune-mediated killing of infected cells takes place (Barnwell et al. 1983a,b) ; (ii) rosetting protects infected cells from opsonization and phagocytosis and hence immune clearance, or from antibody interference with recognition of red blood cell ligands; (iii) immediately after schizont rupture, rosetting protects the body of merozoites from being coated with antibodies that either inhibit reinvasion (reviewed in Anders & Brown 1990) or cause multiple merozoites to invade the same cell (Lyon et al. 1986; Ramasamy et al. 1999) , thereby avoiding a possible compromise to parasite viability; and (iv) binding of parasitized red blood cells to dendritic cells and macrophages protects the parasite from immune clearance by impairing their immune function (reviewed in Urban & Roberts 2002) . Only the first of these hypotheses is supported by experimental evidence, and this is largely indirect. The main source of evidence is the observation from animal models that the parasite's expression of cytoadherence and/or associated variant antigens is downregulated in splenectomized animals (see Hommel et al. 1983; David et al. 1983; Barnwell et al. 1983a,b; Langreth & Peterson 1985; Handunetti et al. 1987; Gilks et al. 1990 ). This suggests that in the absence of the spleen, expression of these proteins on the surface of the red blood cell is costly to the parasite, but is maintained in spleen-intact animals because of the fitness advantage that it incurs. However, evidence on the consequences to parasite multiplication rate of the loss of these phenotypes is confusing. In one study in P. falciparum, there was a reduction in acute phase growth rate in a parasite line that had lost cytoadherence (Langreth & Peterson 1985) , whereas another study in P. knowlesi showed a loss of acute phase growth rate and virulence when surface antigen expression was lost (Barnwell et al. 1983a) . However, in a study on P. chabaudi, simultaneous loss of both cytoadherence and surface antigen expression had no effect on acute phase growth rate, but did show loss of ability to maintain a chronic infection (Gilks et al. 1990) . Furthermore, in the P. chabaudi study, strain-specific immune protection during the acute growth phase required the presence of a spleen (Gilks et al. 1990 ). The transmission consequences of losing cytoadherence or variant antigen expression have never been quantified. The other death-rate hypotheses have yet to be tested.
Finally, cytoadherence may relate to parasite fitness directly through its effects on transmission stage densities, instead of indirectly through asexual parasite growth rate. It is known that in P. falciparum, immature gametocytes sequester (Thomson & Robertson 1935; Smalley et al. 1980) . Molecular data indicate that gametocyte sequestration is mediated through PfEMP-1 (Rogers et al. 1996; Day et al. 1998; Hayward et al. 1999 ) but in vivo Phil. Trans. R. Soc. Lond. B (2004) studies have yet to confirm this. If so, PfEMP-1-mediated cytoadherence of gametocyte-infected cells may promote gametocyte survival by allowing them to sequester and hide from the immune system and hence increase parasite fitness.
(b) Antigenic variation
The immune-based (death rate) hypotheses for how cytoadherence might promote fitness are attractive because the same protein that mediates all three cytoadherence phenotypes in P. falciparum (Baruch et al. 1995; Gardner et al. 1996; Rowe et al. 1997; Chen et al. 1998 )-known as PfEMP-1 (Leech et al. 1984 )-also expresses antigens on the surface of the infected red cell. These antigens are highly variable both between parasite clones and within clones owing to an antigenic switching mechanism. This variability is afforded by the multiple copies in the genome of their coding gene, denoted var (Baruch et al. 1995; Smith et al. 1995; Su et al. 1995) . These antigens are recognized by the immune system in a highly variantspecific way (Marsh & Howard 1986; Forsyth et al. 1989; Newbold et al. 1992; Iqbal et al. 1993; Reeder et al. 1994; Giha et al. 1998; Bull et al. 1999; Giha et al. 1999; Nielsen et al. 2002; Ofori et al. 2002 ) although there appears to be some cross-reactivity between variants (Aguiar et al. 1992; Chattopadhyay et al. 2003) . Low titres (Marsh et al. 1989) and lack of recognition by antibody to the variant expressed by the infecting type has been associated with disease severity in field studies (Bull et al. 1998 (Bull et al. , 2000 Giha et al. 2000; Nielsen et al. 2002) .
A possible mechanism by which variant-specific antibodies provide protection is through disrupting the cytoadherence properties of the PfEMP-1 molecule. Evidence in support of this hypothesis is the strain-specific blocking of binding to endothelial cells in vitro and in vivo Mota et al. 2000) . Further, antibody-mediated abrogation of rosetting has been observed many times Carlson et al. 1990; Wahlgren et al. 1990; Treutiger et al. 1992; Tourneur et al. 1992; Helmby et al. 1993; Rogerson et al. 1996; Barragan et al. 1998; Kun et al. 1998; but see al-Yaman et al. 1995; Rowe et al. 1995; Clough et al. 1998b ) though this has not always been associated with severe disease. Also there may be other parasite molecules besides PfEMP-1 that are involved in cytoadherence (Chaiyaroj et al. 1994; Crabb et al. 1997; Ho & White 1999; Pouvelle et al. 2000; Trenholme et al. 2000) , as well as other variable antigens expressed on the surface of the infected cell in P. falciparum (Fernandez et al. 1999; Kyes et al. 1999) , some of which are known to be recognized by the immune system (Abdel-Latif et al. 2002) . It is therefore not clear whether immune protection is a direct consequence of blocking cytoadherence, nor whether this is mediated through antibody recognition of PfEMP-1 epitopes. Associations between disease and the expression of specific PfEMP-1 ligands and the presence of antibodies to them have been found in only a few of the extensive field surveys Ockenhouse et al. 1991; Newbold et al. 1997; Fried et al. 1998; Ricke et al. 2000) . Moreover, although associations have been found between the incidence of disease and host genetic polymorphisms in cell receptors known to bind malaria parasites through PfEMP-1, these have been in the unexpected direction, i.e. the more common variants in malaria-endemic areas are associated with severe malaria (Fernandez-Reyes et al. 1997; Aitman et al. 2000) . The relationship between PfEMP-1, cytoadherence-related disease and strain-specific immunity is clearly complex.
Interestingly, antigenic types associated with severe disease tend to be more commonly recognized by the population at large than types from patients with mild disease (Bull et al. , 2000 Nielsen et al. 2002) . Antigenic types from older children are also less commonly recognized than types from younger children (Bull et al. 2000; Nielsen et al. 2002) . These observations strongly suggest that immune protection is obtained by acquiring cumulative exposure to the diverse antigenic types of PfEMP-1 circulating in the parasite population, with disease resulting from infection with antigenic types to which the host has not been previously exposed (reviewed in Bull & Marsh 2002) . We further suggest here that the association between common types and disease might indicate a higher fitness (mediated by cytoadherence?), and hence higher population frequency, of the more virulent types.
Cytoadherence aside, there is strong evidence that antigenic variation per se allows the parasite to persist in the face of immunity (reviewed in Brown et al. 1986; Phillips et al. 1997) . By expressing a novel antigen, the immune system is unable to recognize and destroy the parasite. This advantage is most obvious after the acute phase during chronic infection. Although variant antigens are present early in the infection (McLean et al. 1990; Brannan et al. 1994; Peters et al. 2002) , the advantage to acute phase multiplication appears to be zero or small (Voller & Rossan 1969; Brown 1973; Barnwell et al. 1983a; Gilks et al. 1990 ). Like cytoadherence, perhaps the most compelling evidence that antigenic variation confers a fitness advantage is its prevalence throughout the Plasmodium genus. Evidence for antigenic variation exists in all species of parasite studied (P. berghei (Cox 1962) ; P. knowlesi (Brown & Brown 1965) ; P. cynomolgi (Voller & Rossan 1969) ; P. falciparum Biggs et al. 1991; Roberts et al. 1992) ; P. chabaudi (McLean et al. 1982) ; P. fragile (Handunetti et al. 1987) ; and probably P. vivax del Portillo et al. 2001) ). Different sets of genes are responsible in different species (Howard & Barnwell 1985; al-Khedery et al. 1999; del Portillo et al. 2001; Janssen et al. 2001 Janssen et al. , 2002 , suggesting convergent evolution for this phenotype. Interestingly, like P. falciparum, the molecule responsible for both cytoadherence and antigenic variation in P. chabaudi appears to be one and the same, as loss of one of these phenotypes is accompanied by loss of the other (Gilks et al. 1990) . Although a surface antigen of the approximate size of PfEMP-1 has been identified in P. chabaudi schizonts (Newbold et al. 1984) , searches of the P. chabaudi genome for var-like genes have revealed no such homologues (Janssen et al. 2001) . Instead, another multigene family, putatively coding for variant surface antigens has been identified in P. chabaudi, with homologues in P. vivax (del Portillo et al. 2001) , P. yoelii and P. berghei (Janssen et al. 2001 (Janssen et al. , 2002 . If these new putative antigenic variation genes do turn out to also code for cytoadherence, this would suggest convergent evolution for joint control of cytoadherence and antigenic variation, thus strengthening the argument that these phenotypes promote parasite fitness.
Phil. Trans. R. Soc. Lond. B (2004) (c) Red cell invasion and selectivity The other prime molecular candidates for virulence and fitness promoter are the proteins on the merozoite that mediate red cell invasion. Variation in red cell invasion rates may be attributable to differences in the efficiency of red cell invasion by merozoites (invasion efficiency), or to variation in the proportion of red cells that are invadable (selectivity). There are two forms of evidence in relation to the importance of selectivity in invasion rates: one in species with very high red cell selectivity, and the other in species with low selectivity. In P. yoelii, which has a strong predilection for reticulocytes, a mutation that allows parasites to also infect mature red cells leads to very rapid multiplication rate and hypervirulence (Yoeli & Hargreaves 1974; Yoeli et al. 1975) . This has been linked to invasion proteins located in the apex of the merozoite (Freeman et al. 1980; Holder & Freeman 1981; Ogun & Holder 1996; Preiser & Jarra 1998) . In P. falciparum, which invades both immature and mature red cells, strains with lower selectivity (as indicated by a lower proportion of cells infected with more than one parasite) were found to have higher virulence in vivo and growth rate in vitro (Simpson et al. 1999; Chotivanich et al. 2000) . This link between cell selectivity and virulence is further corroborated by evidence that parasites infecting hosts with a genetically defective form of haemoglobin-haemoglobin Ehave high red blood cell selectivity (Chotivanich et al. 2002) and are protected against severe malaria (Hutagalung et al. 1999) . Across-species comparisons, at least between P. falciparum and P. vivax, also support a link between higher cell selectivity and lower virulence (e.g. Miller et al. 2002) but there are multiple possible explanations for these species differences (e.g. see Clark & Cowden 1999) . The lower selectivity of P. falciparum may be due to its ability to use several alternative invasion pathways (Mitchell et al. 1986; Hadley et al. 1987; Perkins & Holt 1988; Soubes et al. 1997; Okoyeh et al. 1999) compared with the unique receptor (the Duffy blood group antigen) used by P. vivax (Miller & Carter 1976 ). However, as for cytoadherence, the effects of parasite ligand diversity and host cell receptor diversity in invasion success are still very unclear. It is also unclear as to how much of the variation in invasion rates is attributable to red cell selectivity compared with invasion efficiency, and therefore how much ligand diversity matters. As for cytoadherence, there is evidence for phenotypic switching mechanisms in invasion pathways (Dolan et al. 1990; Soubes et al. 1997; Preiser et al. 1999) and, once invaded, parasites can rapidly adapt to achieve normal maturation in host cells that normally prevent this (Luzzatto et al. 1983) . Thus there is much complexity in red cell invasion rates yet to be unravelled. The transmission consequences of altered red cell selectivity have not been documented. Thus there is little doubt that invasion success is an important component of parasite survival, but the key properties and their consequences to asexual and gametocyte densities are not yet known.
FUTURE CHALLENGES
Within the context of the evolutionary framework summarized above, we see five areas for further theoretical and empirical work.
(a) The fitness advantages of cytoadherence, antigenic variation and red cell invasion rates As seen above, there are strong, but mostly indirect, arguments that cytoadherence, surface antigens and red cell invasion properties link virulence with asexual multiplication. However, there is little direct evidence so far that these properties do, in fact, promote parasite transmission and fitness. The P. chabaudi model is the ideal system in which to test the birth-rate and death-rate hypotheses outlined above on how these mechanisms might promote replication or transmission. The replication pattern and fitness of parasite lines that vary in rosetting and other cytoadherence, cell selectivity or immune evasion characteristics can be compared, both with and without immune manipulation. In addition, whole genome and proteome screens will soon be able to be performed on parasite material from isogenic lines of P. chabaudi selected for different virulence properties in order to identify relevant molecules.
(b) Mechanisms of multiplication early and late in the infection In the above, we used maximum or average asexual parasitaemia as measures of parasite multiplication and showed them to correlate to virulence, transmission and persistence. Implicit in our argument is the assumption that what maintains population growth during the early stage of the infection is the same or correlated to that which maintains growth later in the infection. Although our studies in P. chabaudi (figure 4) and others in P. falciparum (Gravenor et al. 1995; Simpson et al. 1999 ) also show that early growth rate and maximum parasitaemia are correlated, it is likely that different growth-determining mechanisms operate more strongly at different stages of the infection. What is needed now is a dissection of the processes that lead to successful multiplication at different times in the infection. In addition to cytoadherence, other possible growth mechanisms, such as the number of merozoites per schizont, degree of synchrony, cycle length and merozoite invasion success, need to be studied. Such information may provide new targets for therapy.
(c) The fitness advantages of virulence per se The view we have espoused is the conventional view in the contemporary evolution of virulence literature: virulence is an unavoidable side-effect of fitness-enhancing traits. It is, however, possible that virulence itself brings direct transmission advantages. For instance, some authors have advocated the view that Plasmodium virulence is maintained by natural selection because it directly enhances parasite fitness because sick hosts have reduced anti-vector behaviour (e.g. Day & Edman 1983; Ewald 1994) or attract more mosquitoes to feed when hosts have high gametocyte densities (Ferguson et al. 2003a) . This idea that sickness per se enhances transmission is amenable to direct testing with experimental model systems like P. chabaudi. Although we do not doubt that extremely sick hosts will be less likely to prevent vectors feeding, the key issue is the extent to which transmission is enhanced by such behavioural changes, and this in relation to the growth-related advantages we have described above. It is our experience with P. chabaudi that gametocyte densities are at their lowest at the point in the infection when mice Phil. Trans. R. Soc. Lond. B (2004) appear behaviourally unresponsive to stimuli. And in the context of P. falciparum, given the extremely low gametocyte densities at which patients infect mosquitoes (Boyd et al. 1935; Robertson 1945; Muirhead-Thomson & Mercier 1952; Muirhead-Thomson 1954; Rutledge & Gould 1969) and the long asymptomatic periods of infectivity to mosquitoes (Collins & Jeffery 2003) compared with the short period of sickness, it seems unlikely to us that any changes in host behaviour or attractiveness during the period of acute disease would have a large impact on malaria transmission. Nevertheless, this requires quantitative analysis.
(d ) The selective consequences of mixed infections
Mixed genotype infections are the rule in P. falciparum populations (Day et al. 1992) . This can add an extra layer of complexity to virulence evolution: within-host selection between competing genotypes. This complexity has been of substantial interest among theoreticians (reviewed by Read & Taylor 2001 ) with the most common conclusion being that in-host selection will favour the evolution of more virulent parasites. This is because optimal rates of virulence are altered where competition occurs. In the simplest cases, competing strains reduce the duration of infection for a clone (for instance, by killing the host or prompting a more potent immune response). Thus more virulent clones are favoured by selection because the fitness cost of self-induced host death is reduced: there is no point in saving the golden goose if a competitor will kill it anyway. However, it is now being realized that this theoretical conclusion depends very much on the biological details of the competition (Chao et al. 2000; Brown et al. 2002) . In mixed infections, selection might favour direct chemical attack between combatants, with the result that hosts are less damaged by parasite populations that detrimentally affect each other. Several interventions are likely to reduce the number of competing clones in infections (e.g. bednets) and so it would be highly desirable to understand the fitness consequences of competition in malaria. For instance, transmission-blocking and infection-blocking vaccines could work to reduce virulence if competition does reduce parasite transmission (Gandon et al. 2001) . Competition certainly occurs in rodent models of malaria (reviewed in Read & Taylor 2001; see also de Roode et al. 2003) , and probably in P. falciparum (Bruce et al. 2000) . However, the transmission and virulence consequences of this competition are unclear (Read & Taylor 2001; Read et al. 2002) . In some cases, competitively suppressed clones transmitted as well or even better than they would have done from single clone infections; in other cases, clonal transmission was almost certainly reduced . In P. chabaudi, genetically diverse infections are more virulent (Taylor et al. 1998; Read et al. 2003) , but in P. falciparum, virulence can be increased, decreased or unaltered by diversity (reviewed in Read & Taylor 2001) . Substantially more work is required to elucidate any generalities for virulence in mixed-clone infections.
In addition to the question of how same-species mixed infections affect virulence evolution, there is also the question of how mixed infections with other pathogenic organisms affect virulence. Interactions between malaria virulence and other organisms such as bacteria and HIV can have profound influences on mortality, morbidity and infection rates (Berkley et al. 1999; Holmes et al. 2003) and will therefore affect the optimal level of malaria parasite virulence that evolves. So far, these indirect effects from other diseases have been ignored in theoretical models of virulence evolution and disease epidemiology, and relevant data for building such models are very scarce.
(e) Limits to virulence Most models of virulence evolution have assumed that host death is the constraint that sets the upper limit to virulence. In the P. chabaudi system, we rarely (by intention) encountered host mortality because most of our experiments were performed in the most resistant mouse genotype available, the C57Bl/6J. Thus we did not measure virulence directly, but instead measured morbidity (weight loss and anaemia). Although this correlates to the probability of mortality (Timms et al. 2001; Mackinnon et al. 2002a; Ferguson et al. 2003b ), we do not yet know whether mortality is the primary source of back-selection on virulence. In human malaria, case mortality rarely reaches 1%, but this seems to be sufficient to impose at least some non-negligible cost to lifetime transmission (figure 6). Note that it is not the absolute mortality rates that determine the upper limit to virulence. What matters is the marginal cost versus the marginal gain to lifetime transmission of rising virulence: even if these are slight, the trade-off theory still applies. Nevertheless, there may be sources of selection for lower virulence other than mortality in the vertebrate host. These include reduced infectivity to mosquitoes as a result of a poor-quality blood meal or mortality-driven selection by the mosquito against heavy oocyst loads and hence gametocyte production and virulence in the vertebrate host (Ferguson & Read 2002) . However, so far our data do not provide evidence that virulence in the vertebrate host has an impact on virulence in the vector (Ferguson et al. 2003b ). In addition, it is possible that the mosquito may play a role in limiting the spread of a virulent (or any) mutant through population bottlenecking (Bergstrom et al. 1999; Elena et al. 2001; Wahl et al. 2002) or through resetting of gene expression during meiosis. Studies on the maintenance of virulence phenotypes through population bottlenecks and mosquitoes so far suggest that the vector is not an important constraint on virulence evolution in malaria (M. J. Mackinnon and A. F. Read, unpublished data) .
(f ) Application to other human malaria species Most of the data on malaria virulence pertain to P. falciparum because this is the species that causes most damage. However, P. vivax also contributes significantly to the global burden of morbidity and may well supplant P. falciparum if control of the latter is successful (Mendis et al. 2001 ). An understanding of the forces driving P. vivax virulence and transmission, as well as its ecological interactions with P. falciparum, are therefore required, but at this stage, few relevant data are available. We see no reason why the same sort of virulence-transmissibility relationships as in P. falciparum should not also apply to P. vivax. The fact that mortality due to P. vivax is very low does not preclude such relationships: it is the marginal costs and benefits of virulence that dictate the level of virulence that evolves, not their absolute values. One possible Phil. Trans. R. Soc. Lond. B (2004) reason why P. vivax maintains lower virulence than P. falciparum is that it can generate life-long relapsing infections through reactivation of parasite forms that survive very long periods in the liver or other tissues. Evolutionary theory predicts that the longer the average length of infection, the lower that virulence will evolve (Van Baalen & Sabelis 1995; Day 2003) . Interestingly, the other less virulent human-infecting species, P. ovale and P. malariae, can also generate life-long infections (Garnham 1966) . Nevertheless, there are alternative explanations for why these other species are so much less virulent than P. falciparum, and investigation of why this is the case may yield further leads into malaria virulence factors.
CONCLUSION
The laboratory and field data are overwhelmingly in favour of the hypothesis that virulence in malaria is an unavoidable consequence of natural selection maintaining the transmission-related advantages of high asexual multiplication. This broad-brush, whole-organism view fits well with the current molecular and clinical data on the mechanistic causes of virulence, but a full understanding of how natural selection is acting on specific virulence mechanisms is not yet available. A reductionist approach to biology emphasizes complexity over generality. Although we do not underestimate the obvious complexity of the mechanisms underpinning malaria pathogenesis, we emphasize that what matters to virulence evolution are the fitness consequences of virulence variation at the level of the whole parasite, and their impact on the whole parasite population. Irrespective of the molecular basis, evolutionary analysis of virulence brings us to the conclusion that particular attention should be paid to the transmission consequences of interventions such as vaccines and drugs, as transmission success will ultimately determine how the parasite population will respond to these measures.
ENDNOTES
1 Data came from figs 20, 22, 30, 31, 35 and 65-71 of the Garki Project Report (Molineaux & Gramiccia 1980) . 2 Asexual parasitaemia and gametocytaemia were calculated only from people positive for Plasmodium falciparum and thus do not directly reflect parasite prevalence. 3 Mortality in (c) is the malaria-induced mortality rate among infected people. This was estimated from the all-cause mortality rates (M) from the Garki report by using the age-specific values of mortality rate due to non-malaria causes (␦) as 100, 80, 5, 5, 5, 10 and 31 for age-classes younger than 1, 1-4, 5-8, 9-18, 29-43 and older than 43 years old, respectively, and then estimating the malaria-induced mortality rate ␣ as ␣ = (M Ϫ ␦ )/Y, where Y is the proportion of parasite positive people in the age-class in question (values of 0.6, 0.90, 0.92, 0.76, 0.38, 0.32 and 0.3 for the increasing age-classes). These values of ␦ and ␣ correspond to malaria-attributable fractions of all deaths of 59% in younger than 1-year-olds, 48% in 1-4-year-olds and 39% in the remaining population. Note that the higher values of malaria-induced mortality in infants is consistent with the higher frequency of the HbS allele among infants than older children and adults (Molineaux & Gramiccia 1980) . The HbS allele confers sickle cell anaemia in the homozygous state but has a malaria-protective effect. 4 Clearance time for each new infection is the inverse of clearance rate for each new infection, r. This was estimated from the formula r = h/ln(h/R ϩ 1) to allow for superinfection (Dietz et al. 1980) , where R is the actual clearance rate based on the rate at which people converted from positive to negative from one survey to the next (i.e. cleared all infections), and h is the 'conversion rate' from negative to positive estimated from the longitudinal survey data. Note that the values of R used here were those given as r in the Garki report, as obtained by the method of Bekessy et al. (1976) . As these were based on being slide-positive versus negative for asexual parasites, these were probably overestimates of the true value of R and hence r. 5 Data were taken from table 3b in Tchuinkam et al. (1993) where 86 experimental mosquito feeds were performed on gametocyte carriers. Each point represents the mean of groups classified according to gametocyte density. Data do not include feeds in which zero mosquitoes became infected. 6 Fitness was calculated as W = ␤/(␦ ϩ ␣ ϩ ), where ␤ is the log average gametocyte density, ␦ is the background (non-malaria) mortality rate, ␣ is the malaria-induced mortality rate and is the rate of recovery from the infection. This expression is analogous to the R 0 of the parasite typically used to represent parasite fitness, but is not equivalent because it does not include the effects of mosquito density and biting rate. Gametocyte density was log-transformed because infectivity to mosquitoes linearly increases with log gametocyte density (figure 5b). Here, we used clearance rate from each individual infection ( = r) to allow for superinfection (see figure 5e and endnote 4) as we are interested in the fitness of a parasite per new infection. ␣ was not similarly adjusted but its small value relative to meant that adjustment would have little influence on W. Relative fitness was calculated as W divided by the population weighted average fitness where the weights were the proportion of people in each age class. 7 The near-equal fitness of age-classes at the upper end of the spectrum arises because of the balance between higher gametocyte densities and lower clearance rates in the youngest age-class against their higher mortality rate as compared with older children. Thus the nearly flat fitness function at this end of the spectrum provides support for the virulence trade-off proposed by evolutionary theory. Note that small alterations in values for malaria-induced mortality rate and clearance rate (both of which are estimated with considerable uncertainty from these data) can render the fitness in younger than 1-year-olds slightly less than that in 1-4-year-olds. 
